Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Emergence of Huntington Disease in a Man With a Premorbid Criminal Lifestyle.

Hedlund J, Masterman T.

Front Psychiatry. 2019 Jul 2;10:477. doi: 10.3389/fpsyt.2019.00477. eCollection 2019.

PMID:
31312149
Free Article
2.

Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study.

Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A.

Eur J Clin Pharmacol. 2019 Jun 19. doi: 10.1007/s00228-019-02707-z. [Epub ahead of print]

PMID:
31218371
3.

Infection during childhood and the risk of violent criminal behavior in adulthood.

Blomström Å, Kosidou K, Kristiansson M, Masterman T.

Brain Behav Immun. 2019 Feb 23. pii: S0889-1591(19)30213-2. doi: 10.1016/j.bbi.2019.02.026. [Epub ahead of print]

PMID:
30807840
4.

Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study.

Forsman J, Masterman T, Ahlner J, Isacsson G, Hedström AK.

Eur J Clin Pharmacol. 2019 Mar;75(3):393-400. doi: 10.1007/s00228-018-2586-2. Epub 2018 Nov 3.

PMID:
30392108
5.

Injury-Related Healthcare Use and Risk of Filicide Victimization: A Population-Based Case-Control Study.

Bäckström B, Hedlund J, Masterman T, Sturup J.

J Forensic Sci. 2019 Jan;64(1):166-170. doi: 10.1111/1556-4029.13908. Epub 2018 Sep 5.

PMID:
30184269
6.

Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013.

Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A.

Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1112-1122. doi: 10.1002/pds.4426. Epub 2018 Mar 23.

PMID:
29570893
7.

Pre-offense alcohol intake in homicide offenders and victims: A forensic-toxicological case-control study.

Hedlund J, Forsman J, Sturup J, Masterman T.

J Forensic Leg Med. 2018 May;56:55-58. doi: 10.1016/j.jflm.2018.03.004. Epub 2018 Mar 6.

PMID:
29533206
8.

Psychotropic Medications in Swedish Homicide Victims and Offenders: A Forensic-Toxicological Case-Control Study of Adherence and Recreational Use.

Hedlund J, Forsman J, Sturup J, Masterman T.

J Clin Psychiatry. 2017 Jul;78(7):e797-e802. doi: 10.4088/JCP.16m11244.

PMID:
28617565
9.

Glucose metabolism in completed suicide: a forensic-pathological pilot study.

Forsman J, Keltanen T, Liberg B, Sajantila A, Masterman T, Lindroos K.

Croat Med J. 2017 Feb 28;58(1):34-39.

10.

Intra- and extra-familial child homicide in Sweden 1992-2012: A population-based study.

Hedlund J, Masterman T, Sturup J.

J Forensic Leg Med. 2016 Apr;39:91-9. doi: 10.1016/j.jflm.2016.01.011. Epub 2016 Jan 25.

PMID:
26871306
11.

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.

Villar LM, Costa-Frossard L, Masterman T, Fernandez O, Montalban X, Casanova B, Izquierdo G, Coret F, Tumani H, Saiz A, Arroyo R, Fink K, Leyva L, Espejo C, Simó-Castelló M, García-Sánchez MI, Lauda F, Llufriú S, Álvarez-Lafuente R, Olascoaga J, Prada A, Oterino A, de Andrés C, Tintoré M, Ramió-Torrentà L, Rodríguez-Martín E, Picón C, Comabella M, Quintana E, Agüera E, Díaz S, Fernandez-Bolaños R, García-Merino JA, Landete L, Menéndez-González M, Navarro L, Pérez D, Sánchez-López F, Serrano-Castro PJ, Tuñón A, Espiño M, Muriel A, Bar-Or A, Álvarez-Cermeño JC.

Ann Neurol. 2015 Mar;77(3):447-57. doi: 10.1002/ana.24345. Epub 2015 Jan 30.

PMID:
25581547
12.

Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances.

Liberg B, Klauser P, Harding IH, Adler M, Rahm C, Lundberg J, Masterman T, Wachtler C, Jonsson T, Kristoffersen-Wiberg M, Pantelis C, Wahlund B.

Front Psychiatry. 2014 Dec 4;5:176. doi: 10.3389/fpsyt.2014.00176. eCollection 2014.

13.

Methodological aspects of ELISA analysis of thioredoxin 1 in human plasma and cerebrospinal fluid.

Lundberg M, Curbo S, Reiser K, Masterman T, Braesch-Andersen S, Areström I, Ahlborg N.

PLoS One. 2014 Jul 30;9(7):e103554. doi: 10.1371/journal.pone.0103554. eCollection 2014.

14.

Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort.

Johansson V, Lundholm C, Hillert J, Masterman T, Lichtenstein P, Landén M, Hultman CM.

Mult Scler. 2014 Dec;20(14):1881-91. doi: 10.1177/1352458514540970. Epub 2014 Jul 10.

PMID:
25013151
15.

Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.

Karrenbauer VD, Prejs R, Masterman T, Hillert J, Glaser A, Imrell K.

J Neuroimmunol. 2013 Jan 15;254(1-2):170-3. doi: 10.1016/j.jneuroim.2012.08.011. Epub 2012 Sep 8.

PMID:
22967351
16.

No influence on disease progression of non-HLA susceptibility genes in MS.

Lundström W, Greiner E, Lundmark F, Westerlind H, Smestad C, Lorentzen AR, Kockum I, Link J, Brynedal B, Celius EG, Harbo HF, Masterman T, Hillert J.

J Neuroimmunol. 2011 Aug 15;237(1-2):98-100. doi: 10.1016/j.jneuroim.2011.05.003. Epub 2011 Jul 13.

PMID:
21742385
17.

A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis.

Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF.

Eur J Hum Genet. 2010 Apr;18(4):502-4. doi: 10.1038/ejhg.2009.195. Epub 2009 Nov 4.

18.

Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality.

Kostulas N, Markaki I, Cansu H, Masterman T, Kostulas V.

Age Ageing. 2009 Sep;38(5):590-4. doi: 10.1093/ageing/afp120. Epub 2009 Jul 14.

PMID:
19602513
19.

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.

Villar LM, Masterman T, Casanova B, Gómez-Rial J, Espiño M, Sádaba MC, González-Porqué P, Coret F, Alvarez-Cermeño JC.

J Neuroimmunol. 2009 Jun 25;211(1-2):101-4. doi: 10.1016/j.jneuroim.2009.03.003. Epub 2009 May 13.

PMID:
19443047
20.

HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.

Imrell K, Greiner E, Hillert J, Masterman T.

J Neuroimmunol. 2009 May 29;210(1-2):128-30. doi: 10.1016/j.jneuroim.2009.03.005. Epub 2009 Mar 26.

PMID:
19327846
21.

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.

Thangarajh M, Gomez-Rial J, Hedström AK, Hillert J, Alvarez-Cermeño JC, Masterman T, Villar LM.

Mult Scler. 2008 Nov;14(9):1208-13. doi: 10.1177/1352458508095729. Epub 2008 Aug 28.

PMID:
18755821
22.

Re-utilization of Schwann cells during ingrowth of ventral root afferents in perinatal kittens.

Nilsson Remahl AI, Masterman T, Risling M.

J Anat. 2008 Aug;213(2):194-201. doi: 10.1111/j.1469-7580.2008.00922.x.

23.

The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.

Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, Spurkland A, Lie BA, Palmgren J, Celius EG, Hillert J, Harbo HF.

Eur J Neurol. 2007 Aug;14(8):835-40.

PMID:
17662002
24.

A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis.

Thangarajh M, Masterman T, Hillert J, Moerk S, Jonsson R.

Scand J Immunol. 2007 Jan;65(1):92-8.

25.

Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations.

Lundmark F, Harbo HF, Celius EG, Saarela J, Datta P, Oturai A, Lindgren CM, Masterman T, Salter H, Hillert J.

J Neuroimmunol. 2006 Nov;180(1-2):193-8. Epub 2006 Oct 3.

PMID:
17020785
26.

Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.

Imrell K, Landtblom AM, Hillert J, Masterman T.

Neurology. 2006 Sep 26;67(6):1062-4.

PMID:
17000979
27.

The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis.

Thangarajh M, Masterman T, Helgeland L, Rot U, Jonsson MV, Eide GE, Pirskanen R, Hillert J, Jonsson R.

J Neuroimmunol. 2006 Sep;178(1-2):161-6. Epub 2006 Jul 3.

PMID:
16820216
28.

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.

Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, Schmidt H, Schmidt R, Hillert J, Masterman T, Hogh P, Niino M, Kikuchi S, Maciel P, Santos M, Rio ME, Kwiecinski H, Zakrzewska-Pniewska B, Evangelou N, Palace J, Barcellos LF.

Neurology. 2006 May 9;66(9):1373-83.

PMID:
16682670
29.

Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis.

Karrenbauer VD, Leoni V, Lim ET, Giovannoni G, Ingle GT, Sastre-Garriga J, Thompson AJ, Rashid W, Davies G, Miller DH, Björkhem I, Masterman T.

Clin Neurol Neurosurg. 2006 Jul;108(5):456-60. Epub 2005 Sep 6.

PMID:
16144738
30.

Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis.

Thangarajh M, Masterman T, Rot U, Duvefelt K, Brynedal B, Karrenbauer VD, Hillert J.

J Neuroimmunol. 2005 Oct;167(1-2):210-4.

PMID:
16087247
31.

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA.

Neurology. 2005 Apr 12;64(7):1144-51.

PMID:
15824338
32.

Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis.

Zhang Z, Duvefelt K, Svensson F, Masterman T, Jonasdottir G, Salter H, Emahazion T, Hellgren D, Falk G, Olsson T, Hillert J, Anvret M.

Genes Immun. 2005 Mar;6(2):145-52.

PMID:
15674389
33.

Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis.

Leoni V, Lütjohann D, Masterman T.

J Lipid Res. 2005 Feb;46(2):191-5. Epub 2004 Dec 1.

34.

Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis.

Thangarajh M, Gomes A, Masterman T, Hillert J, Hjelmström P.

J Neuroimmunol. 2004 Jul;152(1-2):183-90.

PMID:
15223251
35.

Modes of action of HLA-DR susceptibility specificities in multiple sclerosis.

Modin H, Olsson W, Hillert J, Masterman T.

Am J Hum Genet. 2004 Jun;74(6):1321-2. No abstract available.

36.

The telltale scan: APOE epsilon4 in multiple sclerosis.

Masterman T, Hillert J.

Lancet Neurol. 2004 Jun;3(6):331. Review. No abstract available.

PMID:
15157846
37.

Diagnostic use of cerebral and extracerebral oxysterols.

Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Björkhem I.

Clin Chem Lab Med. 2004 Feb;42(2):186-91.

PMID:
15061359
38.

Genome-wide linkage screen of a consanguineous multiple sclerosis kinship.

Modin H, Masterman T, Thorlacius T, Stefánsson M, Jónasdóttir A, Stefánsson K, Hillert J, Gulcher J.

Mult Scler. 2003 Mar;9(2):128-34.

PMID:
12708807
39.

Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers.

Leoni V, Masterman T, Patel P, Meaney S, Diczfalusy U, Björkhem I.

J Lipid Res. 2003 Apr;44(4):793-9. Epub 2003 Feb 1.

40.

CTLA4 dimorphisms and the multiple sclerosis phenotype.

Masterman T, Ligers A, Zhang Z, Hellgren D, Salter H, Anvret M, Hillert J.

J Neuroimmunol. 2002 Oct;131(1-2):208-12.

PMID:
12458054
41.

Analysis of nitric oxide synthase genes in cluster headache.

Sjöstrand C, Modin H, Masterman T, Ekbom K, Waldenlind E, Hillert J.

Cephalalgia. 2002 Nov;22(9):758-64.

PMID:
12421162
42.

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis.

Leoni V, Masterman T, Diczfalusy U, De Luca G, Hillert J, Björkhem I.

Neurosci Lett. 2002 Oct 18;331(3):163-6.

PMID:
12383922
43.

APOE genotypes and disease severity in multiple sclerosis.

Masterman T, Zhang Z, Hellgren D, Salter H, Anvret M, Lilius L, Lannfelt L, Hillert J.

Mult Scler. 2002 Apr;8(2):98-103.

PMID:
11990879
44.

Analysis of a CD40 ligand dinucleotide microsatellite in multiple sclerosis.

Dai Y, Masterman T, Huang W, Hillert J.

Eur J Immunogenet. 2002 Apr;29(2):81-5.

PMID:
11918631
45.

HLA-DR15 and age at onset in multiple sclerosis.

Masterman T, Hillert J.

Eur J Neurol. 2002 Mar;9(2):179-80. No abstract available.

PMID:
11882062
46.

Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?

Vorechovsky I, Kralovicova J, Tchilian E, Masterman T, Zhang Z, Ferry B, Misbah S, Chapel H, Webster D, Hellgren D, Anvret M, Hillert J, Hammarstrom L, Beverley PC.

Nat Genet. 2001 Sep;29(1):22-3.

PMID:
11548742
47.

No linkage or association of the nitric oxide synthase genes to multiple sclerosis.

Modin H, Dai Y, Masterman T, Svejgaard A, Sørensen PS, Oturai A, Ryder LP, Spurkland A, Vartdal F, Laaksonen M, Sandberg-Wollheim M, Myhr KM, Nyland H, Hillert J.

J Neuroimmunol. 2001 Sep 3;119(1):95-100.

PMID:
11525805
48.

Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden.

Henriksson F, Fredrikson S, Masterman T, Jönsson B.

Eur J Neurol. 2001 Jan;8(1):27-35.

PMID:
11509078
49.

Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients.

Dai Y, Masterman T, Huang WX, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Oturai A, Ryder LP, Soelberg-Sørensen P, Svejgaard A, Hillert J.

Mult Scler. 2001 Jun;7(3):157-63.

PMID:
11475438
50.

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.

Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J.

Genes Immun. 2001 May;2(3):145-52.

Supplemental Content

Loading ...
Support Center